PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||
Property / summary: None (English) / qualifier | |||||||
readability score: 0.000011549073841409742
|
Latest revision as of 15:37, 7 March 2024
Project Q2906826 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. |
Project Q2906826 in Portugal |
Statements
204,000.0 Euro
0 references
240,000.0 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 July 2022
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Porto
0 references
14 November 2023
0 references
Identifiers
POCI-01-0145-FEDER-031013
0 references